These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 23479674)
1. Thermodynamic stability of domain III from the envelope protein of flaviviruses and its improvement by molecular design. Zidane N; Dussart P; Bremand L; Villani ME; Bedouelle H Protein Eng Des Sel; 2013 Jun; 26(6):389-99. PubMed ID: 23479674 [TBL] [Abstract][Full Text] [Related]
2. Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins. Zidane N; Dussart P; Bremand L; Bedouelle H BMC Infect Dis; 2013 Jul; 13():302. PubMed ID: 23815496 [TBL] [Abstract][Full Text] [Related]
3. Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus. Lisova O; Belkadi L; Bedouelle H J Mol Recognit; 2014 Apr; 27(4):205-14. PubMed ID: 24591178 [TBL] [Abstract][Full Text] [Related]
4. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Gromowski GD; Barrett AD Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070 [TBL] [Abstract][Full Text] [Related]
5. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III. Matsui K; Gromowski GD; Li L; Schuh AJ; Lee JC; Barrett AD Virology; 2009 Feb; 384(1):16-20. PubMed ID: 19101005 [TBL] [Abstract][Full Text] [Related]
6. Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization. Chávez JH; Silva JR; Amarilla AA; Moraes Figueiredo LT Biologicals; 2010 Nov; 38(6):613-8. PubMed ID: 20817489 [TBL] [Abstract][Full Text] [Related]
7. Structural and biophysical analysis of sero-specific immune responses using epitope grafted Dengue ED3 mutants. Kulkarni MR; Islam MM; Numoto N; Elahi M; Mahib MR; Ito N; Kuroda Y Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1438-43. PubMed ID: 26160751 [TBL] [Abstract][Full Text] [Related]
8. Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus. Lisova O; Hardy F; Petit V; Bedouelle H J Gen Virol; 2007 Sep; 88(Pt 9):2387-2397. PubMed ID: 17698647 [TBL] [Abstract][Full Text] [Related]
9. Solution structure of the envelope protein domain III of dengue-4 virus. Volk DE; Lee YC; Li X; Thiviyanathan V; Gromowski GD; Li L; Lamb AR; Beasley DW; Barrett AD; Gorenstein DG Virology; 2007 Jul; 364(1):147-54. PubMed ID: 17395234 [TBL] [Abstract][Full Text] [Related]
10. Computational prediction and experimental characterization of a "size switch type repacking" during the evolution of dengue envelope protein domain III (ED3). Elahi M; Islam MM; Noguchi K; Yohda M; Toh H; Kuroda Y Biochim Biophys Acta; 2014 Mar; 1844(3):585-92. PubMed ID: 24373879 [TBL] [Abstract][Full Text] [Related]
11. High resolution crystal structure of dengue-3 envelope protein domain III suggests possible molecular mechanisms for serospecific antibody recognition. Elahi M; Islam MM; Noguchi K; Yohda M; Kuroda Y Proteins; 2013 Jun; 81(6):1090-5. PubMed ID: 23239402 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains. Li L; Barrett AD; Beasley DW Virology; 2005 Apr; 335(1):99-105. PubMed ID: 15823609 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of recombinant soluble dengue virus 2 envelope domain III protein production in Escherichia coli trxB and gor double mutant. Saejung W; Puttikhunt C; Prommool T; Sojikul P; Tanaka R; Fujiyama K; Malasit P; Seki T J Biosci Bioeng; 2006 Oct; 102(4):333-9. PubMed ID: 17116581 [TBL] [Abstract][Full Text] [Related]
14. Rapid purification of recombinant dengue and West Nile virus envelope Domain III proteins by metal affinity membrane chromatography. Tan LC; Chua AJ; Goh LS; Pua SM; Cheong YK; Ng ML Protein Expr Purif; 2010 Nov; 74(1):129-37. PubMed ID: 20600950 [TBL] [Abstract][Full Text] [Related]
15. Highly specific detection of antibodies to tick-borne encephalitis (TBE) virus in humans using a domain III antigen and a sensitive immune complex (IC) ELISA. Ludolfs D; Reinholz M; Schmitz H J Clin Virol; 2009 Jun; 45(2):125-8. PubMed ID: 19409841 [TBL] [Abstract][Full Text] [Related]
16. Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape. Gromowski GD; Roehrig JT; Diamond MS; Lee JC; Pitcher TJ; Barrett AD Virology; 2010 Nov; 407(2):237-46. PubMed ID: 20832836 [TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of a monoclonal antibody that cross-reacts with the envelope protein from the four dengue virus serotypes. León-Juárez M; García-Cordero J; Santos-Argumedo L; Romero-Ramírez H; García-Machorro J; Bustos-Arriaga J; Gutiérrez-Castañeda B; Sepúlveda NV; Mellado-Sánchez G; Cedillo-Barrón L APMIS; 2013 Sep; 121(9):848-58. PubMed ID: 23331315 [TBL] [Abstract][Full Text] [Related]
18. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein. Goncalvez AP; Purcell RH; Lai CJ J Virol; 2004 Dec; 78(23):12919-28. PubMed ID: 15542644 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of flavivirus membrane fusion. Stiasny K; Fritz R; Pangerl K; Heinz FX Amino Acids; 2011 Nov; 41(5):1159-63. PubMed ID: 19882217 [TBL] [Abstract][Full Text] [Related]
20. Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein. Chen HL; Her SY; Huang KC; Cheng HT; Wu CW; Wu SC; Cheng JW Biopolymers; 2010; 94(3):331-8. PubMed ID: 20069543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]